Literature DB >> 12759807

A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration.

Peter W Marinelli1, Rémi Quirion, Christina Gianoulakis.   

Abstract

RATIONALE: Alcohol stimulates the release of dopamine in the nucleus accumbens (NACB) of rats, mice and humans. There is evidence to suggest that the activation of beta-endorphin (beta-EP) in the mesolimbic pathway by alcohol and other drugs of abuse may be associated with the rise in dopamine levels in the NACB.
OBJECTIVES: The present studies investigate whether the release of beta-EP in the NACB is (1) dependent on the dose of alcohol that is administered, and (2) associated with changes in the extracellular concentrations of the catecholamines dopamine and norepinephrine, and the dopamine metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), in the NACB.
METHODS: Male Sprague-Dawley rats were implanted with a microdialysis probe positioned in the shell region of the NACB. Artificial cerebrospinal fluid was pumped at a rate of 2.3 microl/min in awake and freely moving animals and the dialysate was collected at 30-min intervals. After a baseline period, rats were injected intraperitoneally with either physiological saline or one of three doses of alcohol: 0.8, 1.6, or 2.4 g ethanol/kg body weight. The dialysates collected were analyzed with radioimmunoassay, to estimate the content of beta-EP; and high performance liquid chromatography, to estimate the content of dopamine, norepinephrine, DOPAC and HVA.
RESULTS: Alcohol induced a dose-dependent increase in the extracellular levels of beta-EP and dopamine. However, elevations in the extracellular levels of norepinephrine, DOPAC and HVA did not reach significance. The largest increase in beta-EP and dopamine was observed with the 2.4 g/kg dose.
CONCLUSION: The alcohol-induced release of beta-EP and dopamine in the NACB is dose-dependent, where the highest dose resulted in more pronounced concentrations in the dialysate. Furthermore, the increase in the extracellular levels of dopamine appeared to occur at an earlier time point following alcohol administration, than for beta-EP. These results suggest that alcohol stimulates dopamine and beta-EP in the NACB, but probably does so via independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759807     DOI: 10.1007/s00213-003-1490-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  52 in total

1.  The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice.

Authors:  J P De Waele; D N Papachristou; C Gianoulakis
Journal:  J Pharmacol Exp Ther       Date:  1992-05       Impact factor: 4.030

2.  Characterization of the effects of acute ethanol administration on the release of beta-endorphin peptides by the rat hypothalamus.

Authors:  C Gianoulakis
Journal:  Eur J Pharmacol       Date:  1990-05-03       Impact factor: 4.432

3.  Focal application of alcohols elevates extracellular dopamine in rat brain: a microdialysis study.

Authors:  K M Wozniak; A Pert; A Mele; M Linnoila
Journal:  Brain Res       Date:  1991-02-01       Impact factor: 3.252

4.  Inbred strains of mice with variable sensitivity to ethanol exhibit differences in the content and processing of beta-endorphin.

Authors:  C Gianoulakis; A Gupta
Journal:  Life Sci       Date:  1986-12-15       Impact factor: 5.037

5.  Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Eur J Pharmacol       Date:  1985-09-10       Impact factor: 4.432

6.  Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: effects of novelty and handling and comparison to the nucleus accumbens.

Authors:  M G Feenstra; M H Botterblom; S Mastenbroek
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

7.  Central administration of an opiate antagonist decreases oral ethanol self-administration in rats.

Authors:  C J Heyser; A J Roberts; G Schulteis; G F Koob
Journal:  Alcohol Clin Exp Res       Date:  1999-09       Impact factor: 3.455

8.  The effects of selective catecholamine depletions by 6-hydroxydopamine on ethanol preference in rats.

Authors:  Z W Brown; Z Amit
Journal:  Neurosci Lett       Date:  1977-09       Impact factor: 3.046

9.  The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat.

Authors:  S Rassnick; L Stinus; G F Koob
Journal:  Brain Res       Date:  1993-09-24       Impact factor: 3.252

10.  Simultaneous monitoring of dopamine release in rat frontal cortex, nucleus accumbens and striatum: effect of drugs, circadian changes and correlations with motor activity.

Authors:  R D O'Neill; M Fillenz
Journal:  Neuroscience       Date:  1985-09       Impact factor: 3.590

View more
  58 in total

1.  Ethanol-induced activation of AKT and DARPP-32 in the mouse striatum mediated by opioid receptors.

Authors:  Karl Björk; Anton Terasmaa; Hui Sun; Annika Thorsell; Wolfgang H Sommer; Markus Heilig
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Sex differences in the effects of adolescent social deprivation on alcohol consumption in μ-opioid receptor knockout mice.

Authors:  Yuki Moriya; Yoshiyuki Kasahara; F Scott Hall; Yasufumi Sakakibara; George R Uhl; Hiroaki Tomita; Ichiro Sora
Journal:  Psychopharmacology (Berl)       Date:  2014-11-04       Impact factor: 4.530

3.  Voluntary alcohol drinking enhances proopiomelanocortin gene expression in nucleus accumbens shell and hypothalamus of Sardinian alcohol-preferring rats.

Authors:  Yan Zhou; Giancarlo Colombo; Keiichi Niikura; Mauro A M Carai; Teresa Femenía; Maria S García-Gutiérrez; Jorge Manzanares; Ann Ho; Gian Luigi Gessa; Mary Jeanne Kreek
Journal:  Alcohol Clin Exp Res       Date:  2012-06-22       Impact factor: 3.455

4.  Effects of cannabidiol plus naltrexone on motivation and ethanol consumption.

Authors:  Adrián Viudez-Martínez; María S García-Gutiérrez; Ana Isabel Fraguas-Sánchez; Ana Isabel Torres-Suárez; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2018-07-01       Impact factor: 8.739

5.  Involvement of the beta-endorphin neurons of the hypothalamic arcuate nucleus in ethanol-induced place preference conditioning in mice.

Authors:  Raúl Pastor; Laura Font; Marta Miquel; Tamara J Phillips; Carlos M G Aragon
Journal:  Alcohol Clin Exp Res       Date:  2011-10-20       Impact factor: 3.455

6.  Effects of acute ethanol on beta-endorphin release in the nucleus accumbens of selectively bred lines of alcohol-preferring AA and alcohol-avoiding ANA rats.

Authors:  Minh P Lam; Harri Nurmi; Noora Rouvinen; Kalervo Kiianmaa; Christina Gianoulakis
Journal:  Psychopharmacology (Berl)       Date:  2009-11-26       Impact factor: 4.530

7.  Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.

Authors:  Sarah Sushchyk; Zheng-Xiong Xi; Jia Bei Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-02-22       Impact factor: 4.030

8.  Motor stimulant effects of ethanol and acetaldehyde injected into the posterior ventral tegmental area of rats: role of opioid receptors.

Authors:  María José Sánchez-Catalán; Lucía Hipólito; Teodoro Zornoza; Ana Polache; Luis Granero
Journal:  Psychopharmacology (Berl)       Date:  2009-02-24       Impact factor: 4.530

9.  Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.

Authors:  Brendan M Walker; George F Koob
Journal:  Neuropsychopharmacology       Date:  2007-05-02       Impact factor: 7.853

10.  Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.

Authors:  Chloe M Erikson; Gengze Wei; Brendan M Walker
Journal:  Neuropharmacology       Date:  2018-07-31       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.